Literature DB >> 29685572

Risk Factors and Trends in Incidence of Heart Failure Following Acute Myocardial Infarction.

Jennifer Wellings1, John B Kostis2, Davit Sargsyan1, Javier Cabrera1, William J Kostis1.   

Abstract

Patients who develop heart failure (HF) after an acute myocardial infarction (AMI) are at higher risk of adverse fatal and nonfatal outcomes. Published studies on the incidence and associations of HF after infarction have been contradictory, with some reporting increasing and others decreasing incidence. Between 2000 and 2015, 109,717 patients admitted for a first AMI in New Jersey were discharged alive. In the 15 years from 2000 to 2015, the rates of admission for HF in AMI patients who were discharged alive decreased by 60%, from 3.48% to 1.4%, at 1-year follow-up. At 5 years of follow-up, the decline was more pronounced, from 7.21% to 1.4%, an 80% decline. All-cause death, and the combined end point of admission for HF or death, showed decreasing trends. Cox regression indicated a decrease in the risk of admission for HF over time (hazard ratio [HR] 0.955, 95% confidence interval [CI] 0.949 to 0.961). Younger age, male gender, and commercial insurance were associated with lower HRs for HF (p <0.001), whereas history of hypertension, diabetes, kidney, or lung disease were associated with higher HRs (p <0.001). There was no significant difference in the rate of HF between subendocardial and transmural AMI (adjusted OR was 0.96, CI 0.90 to 1.03, p = 0.241). Revascularization was associated with a marked decrease in HF admissions (adjusted OR 0.22, 95% CI 0.19 to 0.25, p <0.001 for percutaneous coronary intervention and OR 0.44, 95% CI 0.38 to 0.51, p <0.001 for CABG). In conclusion, the rate of admission for HF after discharge for a first myocardial infarction as well as all-cause death decreased markedly from 2000 to 2015.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29685572     DOI: 10.1016/j.amjcard.2018.03.005

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Clinical burden, risk factor impact and outcomes following myocardial infarction and stroke: A 25-year individual patient level linkage study.

Authors:  Anoop S V Shah; Kuan Ken Lee; Jesús Alberto Rodríguez Pérez; Desmond Campbell; Federica Astengo; Jennifer Logue; Peter James Gallacher; Srinivasa Vittal Katikireddi; Rong Bing; Shirjel R Alam; Atul Anand; Catherine Sudlow; Colin M Fischbacher; Jim Lewsey; Pablo Perel; David E Newby; Nicholas L Mills; David A McAllister
Journal:  Lancet Reg Health Eur       Date:  2021-08

2.  Changing Trends in the Landscape of Patients Hospitalized With Acute Myocardial Infarction (2001 to 2011) (from the Worcester Heart Attack Study).

Authors:  Regino Mercado-Lubo; Jorge Yarzebski; Darleen Lessard; Joel Gore; Robert J Goldberg
Journal:  Am J Cardiol       Date:  2019-12-13       Impact factor: 2.778

Review 3.  Diabetes mellitus and risk of new-onset and recurrent heart failure: a systematic review and meta-analysis.

Authors:  Satoru Kodama; Kazuya Fujihara; Chika Horikawa; Takaaki Sato; Midori Iwanaga; Takaho Yamada; Kiminori Kato; Kenichi Watanabe; Hitoshi Shimano; Tohru Izumi; Hirohito Sone
Journal:  ESC Heart Fail       Date:  2020-07-29

4.  Uses and opportunities for machine learning in hypertension research.

Authors:  Dhammika Amaratunga; Javier Cabrera; Davit Sargsyan; John B Kostis; Stavros Zinonos; William J Kostis
Journal:  Int J Cardiol Hypertens       Date:  2020-03-19

5.  Spatiotemporal dynamics of macrophage heterogeneity and a potential function of Trem2hi macrophages in infarcted hearts.

Authors:  Seung-Hyun Jung; Byung-Hee Hwang; Sun Shin; Eun-Hye Park; Sin-Hee Park; Chan Woo Kim; Eunmin Kim; Eunho Choo; Ik Jun Choi; Filip K Swirski; Kiyuk Chang; Yeun-Jun Chung
Journal:  Nat Commun       Date:  2022-08-06       Impact factor: 17.694

6.  Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank.

Authors:  Tripti Rastogi; Frederick K Ho; Patrick Rossignol; Thomas Merkling; Javed Butler; Andrew Clark; Timothy Collier; Christian Delles; J Wouter Jukema; Stephane Heymans; Roberto Latini; Alexandre Mebazaa; Pierpaolo Pellicori; Peter Sever; Jan A Staessen; Lutgarde Thijs; John G Cleland; Naveed Sattar; Faiez Zannad; Nicolas Girerd
Journal:  Eur J Heart Fail       Date:  2022-04-18       Impact factor: 17.349

7.  Readmission and mortality among heart failure patients with history of hypertension in a statewide database.

Authors:  Michail Giakoumis; Davit Sargsyan; John B Kostis; Javier Cabrera; Sanketkumar Dalwadi; William J Kostis
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-07       Impact factor: 3.738

Review 8.  Heart failure after myocardial infarction: incidence and predictors.

Authors:  Dominik Jenča; Vojtěch Melenovský; Josef Stehlik; Vladimír Staněk; Jiří Kettner; Josef Kautzner; Věra Adámková; Peter Wohlfahrt
Journal:  ESC Heart Fail       Date:  2020-12-14

9.  Comparison of clinical outcomes and left ventricular remodeling after ST-elevation myocardial infarction between patients with and without diabetes mellitus.

Authors:  Naoyuki Akashi; Takunori Tsukui; Kei Yamamoto; Masaru Seguchi; Yousuke Taniguchi; Kenichi Sakakura; Hiroshi Wada; Shin-Ichi Momomura; Hideo Fujita
Journal:  Heart Vessels       Date:  2021-03-14       Impact factor: 2.037

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.